Quanterix Corp at JPMorgan Healthcare Conference Transcript
All right. We're going to go ahead and get started. Good afternoon. I'm Tycho Peterson from the Life Science team. It's my pleasure to introduce Quanterix. We'll do a breakout right after in the Yorkshire Room. And with that, let me turn it over to Kevin.
Thank you very much, Tycho. It's always a pleasure to be here. We've got some exciting news to discuss today, representing Quanterix. Before starting, please consult your regulatory filings before investing in our stock.
Today, I'm going to discuss 2 things around the company: one is we have a pretty incredible story over the last 5 years on the research side, where we're executing, and it's pretty strong execution story. Today, we'll further build upon that because we will give some revenue indication of our Q4 performance. But I also wanted to talk about some aspiration around diagnostics and some of the ways we think we can disrupt moving forward
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |